Atopic Dermatitis as a Paradoxical Effect of Secukinumab for the Treatment of Psoriasis

In the therapeutic arsenal to treat moderate to severe psoriasis, the new agents are secukinumab and ustekinumab, which are fully human monoclonal antibodies, directed against IL-17A and IL-12/23, respectively, which have been shown to be effective and safe in several studies. Their side effects are...

Full description

Saved in:
Bibliographic Details
Main Authors: Eduardo V. Mendes Roncada (Author), Victoria Romanini Brambilla (Author), Beatriz Freitas Filitto (Author), Mariana Pirajá Genta (Author), Marilda Ap. M. Morgado de Abreu (Author)
Format: Book
Published: Karger Publishers, 2021-07-01T00:00:00Z.
Subjects:
Online Access:Connect to this object online.
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

Connect to this object online.

3rd Floor Main Library

Holdings details from 3rd Floor Main Library
Call Number: A1234.567
Copy 1 Available